Labshake search
Citations for R&D Systems :
201 - 250 of 3006 citations for 7 CHLORO 1 METHYL 1H PYRAZOLO 4 3 B PYRIDINE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... onto Matrigel (BD Biosciences)-coated culture plates at a ratio of 1:4∼1:8 supplemented with ROCK inhibitor Y-27632 (10 mM, R&D systems). To monitor and ensure the genetic stability of the cells ...
-
bioRxiv - Developmental Biology 2022Quote: ... Mesoderm lineage explants were generated using recombinant BMP4/7 heterodimer protein (R&D Systems) at a final concentration of 20g/mL in 1xMMR supplemented with 0.1% BSA ...
-
bioRxiv - Immunology 2019Quote: ... 5 ng/ml IL-7 and 5 ng/ml IL-15 (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Immunology 2023Quote: ... in media containing 10 ng/ml IL-7 (BT-007-010; R&D Systems) at 37°C in 5% CO2 and after 3.5 days ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/ml IL-7 and 5 ng/ml IL-15 (R&D Systems). After 14 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.3% Triton X-100) for 1 hour at room temperature and incubated with primary antibody against VE-cadherin (AF938, R&D Systems, 1:100) overnight at 4°C ...
-
bioRxiv - Immunology 2021Quote: ... Interleukin 4 (IL-4) and Interferon Gamma (IFNy) from R&D Systems/Bio-Techne (R&D Systems/Bio-Techne ...
-
bioRxiv - Neuroscience 2023Quote: ... explants were incubated overnight in PBS 3% BSA with primary antibody: anti-Robo1 (R&D Systems, 1:400) or anti-Robo2 (gift from Dr Alain Chédotal 53 ...
-
bioRxiv - Neuroscience 2019Quote: ... Stattic (6-Nitrobenzo[b]thiophene 1,1-dioxide) was supplied by R&D Systems (UK).
-
bioRxiv - Immunology 2019Quote: ... We established in vitro quantification of granzyme B (antibody sets from R&D Systems) and perforin (antibody sets from MABTECH) ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Cell Biology 2020Quote: ... and were treated with 10 ng/mL TGF-β1 (R&D systems, 240-B) or IMRC conditioned medium where specified ...
-
bioRxiv - Immunology 2022Quote: ... SARS-CoV-2 B.1.1.529 S GCN4-IZ-2P (11061-CV, R&D Systems), MERS-CoV S GCN4-IZ-2P (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... and granzyme B DuoSet ELISA kits were purchased from R&D Systems (Minneapolis, MN). OVA 257-264 (SIINFEKL peptides) ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Cancer Biology 2022Quote: ... incubated overnight at 4°C in the following primary antibodies: T-LCK (1:1000 R&D Systems), T-LCK (1:1000 Proteintech) ...
-
bioRxiv - Neuroscience 2021Quote: ... incubated for 5 days at 4°C with Car4 primary antibody (1:500, RRID:AB_10013483; R&D Systems), rinsed ...
-
bioRxiv - Neuroscience 2023Quote: ... The cells were labeled with anti-human SSEA-4 APC-conjugated antibody (1:100, R&D Systems) at 37°C for 30 minutes ...
-
bioRxiv - Neuroscience 2023Quote: ... Tissues were stained overnight at 4°C with mouse CD45 antibody (1:200; Af114, R&D Systems). The next day ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 25 ng/ml bone morphogenetic protein-4 (BMP-4, R&D Systems) and 1 μM all-trans Retinoid Acid (RA ...
-
bioRxiv - Cell Biology 2022Quote: ... and 10 ng/mL bone morphogenetic protein 4 (BMP-4) (R&D System) for five days ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems; Bio-techne, Inc.) until use.
-
bioRxiv - Cell Biology 2023Quote: ... positive selection marker: Mouse anti-integrin alpha 7 Alexa fluor 647 (FAB3518R, R&D Systems). Cells were rinsed ...
-
bioRxiv - Neuroscience 2023Quote: HiPSCs-derived microglia at day 7 of differentiation were stimulated with IFNγ (R&D Systems) 100 ng/ml for 72 hours ...
-
bioRxiv - Cell Biology 2023Quote: ... and differentiating spermatogonia marker c-KIT (day 7; 0.6 µg/ml, R&D Systems AF2944) overnight at 4 °C ...
-
bioRxiv - Bioengineering 2019Quote: Stage 1: 3 days in S1 basal media with 100 ng/ml Activin A (R&D Systems; 338-AC) and 3 μM CHIR99021 (Stemgent ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by incubation with the appropriate primary antibodies in blocking solution at 4°C overnight (1:1000 rabbit anti-IBA1 (FujiFilm Wako Chemicals, Cat # 019-19741) & 1:500 sheep anti-TREM2 (R&D Systems, Cat # AF1729)) ...
-
bioRxiv - Immunology 2021Quote: ... anti-IL-4 (1 μg/ml) R&D Systems Cat# MAB204) and anti-IFN-γ (1 μg/ml R&D Systems Cat#MAB-285). Differentiation of Th17 cells was confirmed by measuring IL-17 expression by quantitative real-time PCR ...
-
bioRxiv - Molecular Biology 2022Quote: ... samples were incubated at 4°C overnight with the respective primary antibodies (LDLR, R&D Systems, 1:200 and CAP1, Santa Cruz, 1:1,000). Cells were then washed with PBS and incubated with the appropriate fluorescent secondary antibody (all from Thermo Fisher ...
-
bioRxiv - Systems Biology 2024Quote: ... incubated overnight at 4°C in PBST with the following primary antibodies: mouse SHH supernatant (DSHB, 1:70) and sheep ARX (R&D systems, 1:100), washed in PBST ...
-
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV epitopesbioRxiv - Immunology 2020Quote: ... and 1000 IU/ml of interleukin 4 (IL-4; R&D Systems, Minneapolis, MN) to differentiate them into immature dendritic cells (iDC ...
-
bioRxiv - Physiology 2020Quote: ... B-cells were stained using rat anti-B220/CD45R antibodies (R&D systems, Cat# MAB1217)
-
bioRxiv - Bioengineering 2020Quote: ... and granzyme B DuoSet ELISA kits were purchased from R&D Systems (Minneapolis, MN, USA). Carboxyfluorescein succinimidyl ester (CFSE) ...
-
bioRxiv - Immunology 2022Quote: ... Primary B cell complete media also contains 5 ng/ml of BAFF (R&D Systems).
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Cell Biology 2023Quote: ... all the wells were treated with TGFb1 (R&D systems, #240-B-010, 5ng/ml). Drugs were used at a concentration of 10µM ...
-
bioRxiv - Developmental Biology 2020Quote: ... the membranes were incubated overnight at 4°C with anti-Gremlin1 antibody (R&D systems, AF956, 1:1000) or anti-βActin (Santa Cruz ...
-
bioRxiv - Neuroscience 2020Quote: ... The blots were incubated overnight at 4 °C with goat anti Dscam (AF3666, 1:500, R&D systems) and mouse anti-tubulin (12G10 ...
-
bioRxiv - Cancer Biology 2020Quote: ... Membranes were incubated overnight at 4°C with primary antibodies against pLCK (Y394) (1:1000) (R&D Systems), GAPDH (1:1000 ...
-
bioRxiv - Cell Biology 2022Quote: ... and incubated overnight at 4°C with antibodies against ACE2 (1:400; R&D systems, Minneapolis, MN, USA), TMPRSS2 (1:1000 ...
-
bioRxiv - Molecular Biology 2023Quote: ... The cell pellet was stained for 1 hour at 4°C with primary ACE2 antibody (R&D systems #AF933 ...
-
bioRxiv - Neuroscience 2020Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; 10 μM; R&D Systems) was then added to determine the effect of AMPA receptor blockade on ePSCs ...
-
bioRxiv - Microbiology 2022Quote: ... 100 uM of fluorogenic tripeptide substrate Methionine-Glycine-Proline-7-amido-methylcoumarin (R&D Systems ES017); and 2 ug/mL of MetAP enzyme (R&D Systems 3537-ZN) ...
-
bioRxiv - Immunology 2022Quote: ... USA) and cultured for 7 days with 20 ng/ml recombinant M-CSF (R&D Systems) to allow them to differentiate to macrophages ...
-
bioRxiv - Systems Biology 2023Quote: ... BMDMs were stimulated on day 7 with the appropriate doses of IL-6 (R&D Systems) and IL-10 (R&D Systems ...